Gallstone disease

A 58-year-old woman is referred with a scan that found gallstones during a renal colic work-up. She has had two episodes of post-prandial right upper quadrant pain this year, each settling within an hour. Every decision you will make for her — operate or observe, which symptoms actually belong to the stones, how to hunt a duct stone, and what to do about the calcified gallbladder wall the radiologist mentioned — is mapped by cohort, trial and guideline. This page is the overview: it gives you the numbers for watchful waiting, the pathway for duct stones, and the special syndromes, and it cross-references the acute cholecystitis and acute cholangitis topics rather than duplicating them.^[5][1][21]

Definition and classification — the spectrum that organises everything

Gallstone disease is best taught as five stations on one line.^[5]

Asymptomatic (silent) stones are stones found incidentally in a patient with no attributable symptoms — the default state of the disease, and the subject of the natural-history section below.^[5] Biliary colic is the pain of transient impaction: a stone obstructs the cystic duct or infundibulum, the gallbladder contracts against it, and the pain resolves when the stone falls back or passes. The moment the obstruction is sustained, the disease becomes acute cholecystitis — a different topic with its own TG18 criteria and WSES pathway, cross-referenced here and covered separately.^[21] Ductal complications are choledocholithiasis, cholangitis and gallstone pancreatitis — stones that have left the gallbladder. Between 10% and 18% of people undergoing cholecystectomy for gallstones harbour common bile duct stones, which is why the duct-stone pathway on this page is part of every cholecystectomy work-up, not an exotic add-on.^[3]

The fistulising syndromes are chronic pressure-erosion diseases. Mirizzi syndrome begins with a stone impacted at the gallbladder infundibulum causing a pressure ulcer, an inflammatory response, first external obstruction of the bile duct and eventually erosion into it as a cholecystocholedochal or cholecystohepatic fistula.^[14] A cholecystoenteric fistula is the same process eroding into bowel — and the two are a continuum: in Beltrán's series of 5,673 cholecystectomies, 327 (5.7%) had Mirizzi syndrome and 105 (1.8%) a cholecystoenteric fistula, and 89.5% of the fistula patients had an associated Mirizzi syndrome.^[15] Porcelain gallbladder is gallbladder wall calcification, defined radiographically, with two patterns that carry different cancer risks — selective mucosal versus complete intramural calcification — detailed in the syndromes section.^[17][18]

Epidemiology and risk factors

Gallstones are common, with prevalences as high as 60–70% in American Indians and 10–15% in white adults of developed countries.^[13] Stinton's classification divides the risk factors the way examiners want them: immutable — female gender, increasing age, and ethnicity/family genetic traits — and modifiable — obesity, the metabolic syndrome, rapid weight loss, certain diseases (cirrhosis and Crohn disease), gallbladder stasis (from spinal cord injury or drugs such as somatostatin), and lifestyle.^[13]

The GREPCO women's cohort gives the incidence texture: over 10 years in a rural Italian population, the overall incidence of gallstone disease was 6.3% (5.5% new gallstones and 0.8% cholecystectomies), only 23.1% of the women with gallstones were aware of their condition, and 76.9% had never suffered biliary pain. New gallstone disease was independently associated with body mass index and parity.^[6] Bariatric surgery is the modern accelerant: the meta-analytic risk of de novo gallstone disease after bariatric surgery is 20.7% and of symptomatic disease 8.2% — the numbers behind the prophylaxis debate in the special-populations section.^[19]

Natural history — the evidence base for watchful waiting

This is the section that wins or loses the fellowship answer, so quote it precisely.^[5][7]

GREPCO (Hepatology 1995). In initially asymptomatic carriers, the cumulative probability of developing biliary colic was 11.9% at 2 years, 16.5% at 4 years and 25.8% at 10 years. The cumulative probability of complications after 10 years was 3.0% in the initially asymptomatic group and 6.5% in the symptomatic group — not significantly different. The authors' own conclusion is the one to remember: the natural history of gallstones is less benign than is generally considered — colic is common, even if severe complications are not.^[5]

Friedman (Am J Surg 1993). Serious symptoms and complications develop in about 1–2% of patients with asymptomatic gallstones annually, with fewer complications in later years than in the years soon after discovery. In mildly symptomatic patients, complications run perhaps 1–3% per year, and cholecystectomy for severe symptoms is undertaken in 6–8% per year early on, declining with follow-up. Friedman also fixes the frequency order of severe complications: acute cholecystitis is the most common; obstructive jaundice, cholangitis, pancreatitis and gallbladder cancer are infrequent.^[7]

The Copenhagen unaware-carrier cohorts (Shabanzadeh). Followed for a median of 17.4 years with 99.7% completeness, 19.6% of participants with gallstones they did not know about developed a clinical event — 8.0% complicated, 11.6% uncomplicated. The conclusion sentence is a viva answer in itself: fewer than 20% of subjects with gallstones develop clinical events, and larger, multiple and older gallstones are associated with events.^[10]

The 2026 meta-analysis ties the cohorts together: the cumulative incidence proportion of symptomatic progression in asymptomatic gallstones was 0.10 at 5 years, 0.19 at 10 years and 0.26 at 15 years.^[12]

After a first episode of colic, Ransohoff's review supplies the counselling number: about 30% of persons who have had pain do not have further episodes of pain — which is why a single mild episode does not mandate the operating list, and why the decision analysis below came out against prophylaxis.^[9]

What predicts events — the Shabanzadeh prediction rule

Not all silent stones are equal. Stones larger than 10 mm were associated with all events (hazard ratio 2.31), with acute cholecystitis (HR 9.49), with uncomplicated events including cholecystectomy; multiple stones were associated with all events (HR 1.68), complicated events (HR 2.52) and — strikingly — common bile duct stones (HR 11.83). The highest-risk phenotype is the woman with multiple large stones.^[10] Symptoms matter too, and asymmetrically: events tracked with high pain intensity at baseline, pain at night (complicated events), and epigastric pain of longer duration needing medication (uncomplicated events) — while dyspepsia and irritable-bowel-type symptoms showed no association with events at all.^[11]

Pathophysiology — four mechanisms, four syndromes

Biliary colic versus cholecystitis. A migrating stone that transiently impacts at the cystic duct produces colic; a stone that stays impacted produces the sustained obstruction, distension and inflammatory cascade of acute cholecystitis. The clinical distinction — pain that resolves versus pain that persists with fever, leucocytosis and Murphy's sign — is what changes management, and the cholecystitis topic owns that pathway.^[21]

Mirizzi syndrome is a pressure-ulcer disease: an impacted infundibular stone ulcerates, the surrounding inflammation first compresses the bile duct externally, and continued erosion produces a cholecystocholedochal or cholecystohepatic fistula.^[14] Its importance is not its frequency — under 1% a year in Western countries — but its danger: it is associated with potentially serious surgical complications such as bile duct injury, because the duct the surgeon is trying to preserve is fused into the inflammatory mass.^[14]

Gallstone ileus is mechanical intestinal obstruction from gallstone impaction within the gastrointestinal tract, accounting for less than 1% of intestinal obstructions.^[16] The stone reaches the bowel through a cholecystoenteric fistula — the Beltrán continuum above — and impacts where the calibre narrows, typically the terminal ileum. It is a disease of the elderly, most of whom carry concomitant medical illness, which is what drives its mortality.^[16]

Porcelain gallbladder is the end of chronic inflammation: sustained inflammation, fibrosis and scarring with calcium deposition in the wall. The strong correlation with gallstones — over 60% — establishes cholelithiasis as the primary risk factor.^[18]

Bariatric stones. Rapid weight loss is one of Stinton's modifiable risk factors, and bariatric surgery concentrates it: the mechanism section of the prophylaxis debate is ursodeoxycholic acid, which in the randomised-trial meta-analysis reduced gallstone formation (OR 0.25), symptomatic gallstone disease (OR 0.29) and subsequent cholecystectomy (OR 0.33).^[13][20]

Clinical presentation

True biliary colic is severe, steady pain — not a cramp, not a catch — in the right upper quadrant or epigastrium, typically post-prandial or nocturnal, lasting tens of minutes to a few hours and resolving completely between attacks. The Copenhagen symptom study tells you which features carry prognostic weight in unaware carriers: high pain intensity, night pain, and epigastric pain of longer duration needing medication predicted later events; dyspepsia and irritable-bowel symptoms did not.^[11]

Choledocholithiasis presents as obstructive jaundice with cholestatic liver tests and duct dilatation, but suspect it without jaundice when liver function tests are cholestatic or the duct is dilated on ultrasound — that is exactly the population the ESGE probability pathway exists to catch.^[1] Mirizzi syndrome should be thought of whenever obstructive jaundice coexists with a contracted, stone-filled gallbladder.^[14] Gallstone ileus presents as ordinary small bowel obstruction — colicky pain, vomiting, distension, absolute constipation — in an elderly patient, often with no prior laparotomy; the signs are nonspecific, which is why the diagnosis is radiological and why the triad matters below.^[16]

Investigations and the choledocholithiasis pathway

Ultrasound is the first test for gallbladder stones, and for suspected duct stones the ESGE is explicit: liver function tests and abdominal ultrasonography are the initial diagnostic steps.^[1] The pathway then stratifies by evidence:^[1]

• Stone evident on ultrasound → proceed to duct clearance (ERCP, or intraoperative clearance if the single-stage route is chosen).
• Persistent clinical suspicion but insufficient evidence on ultrasound → endoscopic ultrasound or MRCP.^[1]
• Confirmed duct stones → ESGE recommends offering stone extraction to all patients with common bile duct stones, symptomatic or not, who are fit enough to tolerate the intervention.^[1]
• Difficult stones → limited sphincterotomy combined with endoscopic papillary large-balloon dilation as first line; cholangioscopy-assisted intraluminal lithotripsy (electrohydraulic or laser) is the effective and safe next step.^[1]
• Irretrievable stones that warrant drainage → temporary biliary plastic stent.^[1]

When duct stones complicate into cholangitis, the ESGE drainage clock is: severe cholangitis — as soon as possible, and within 12 hours for septic shock; moderate — within 48–72 hours; mild — elective.^[1] The full cholangitis pathway, including the Tokyo Guidelines severity grading, belongs to the acute cholangitis topic.

CT is the test for the fistulising syndromes. Gallstone ileus is diagnosed by the triad made visible: a cholecystoenteric communication (with loss of the gallbladder–duodenal fat plane and pneumobilia), an ectopic calcified stone, and dilated small bowel.^[16][24] Porcelain gallbladder is eggshell or ring calcification of the wall on CT or ultrasound.^[17][23]

The incidental IOC stone debate. A positive intraoperative cholangiogram at cholecystectomy forces a decision with weak evidence behind it — the systematic review is entirely non-randomised. The numbers to quote: in patients observed after a positive IOC, 20.9% went on to have symptomatic retained stones; in patients directed to ERCP for a positive IOC, persistent stones were found in only 50.6% — meaning roughly half of ERCPs done for IOC findings encounter a duct that has already cleared itself. The review's conclusion is that there is some evidence asymptomatic stones may be safely observed, and a conservative strategy could be more widely considered when the risks of biliary intervention are high.^[22]

Non-operative management — when doing nothing is the evidence-based choice

For asymptomatic stones, the decision analyses are unambiguous. Ransohoff's 1983 survival analysis: prophylactic cholecystectomy slightly decreases survival — a 30-year-old man choosing prophylactic surgery over expectant management would lose, on average, 4 days of life; a 50-year-old man would lose 18 days.^[8] The 1993 follow-through states the rule in plain terms: for persons with asymptomatic gallstones, the natural history is so benign that treatment is generally not recommended — watchful waiting is the best course.^[9] Friedman's cost-effectiveness analyses found no substantial difference in life expectancy between immediate open cholecystectomy and watchful waiting for asymptomatic disease.^[7] The cohort data above supply the event rates that make those analyses true: 1–2% per year at worst, fewer than 20% over 17 years.^[7][10]

For mildly symptomatic disease, the same authors frame the middle ground: about 30% never have another pain episode, complications run 1–3% per year, and cholecystectomy is undertaken in 6–8% per year early on — a shared-decision conversation, not an automatic listing.^[7][9]

For the bariatric patient, the evidence has inverted the old reflex. Concomitant prophylactic cholecystectomy at bariatric surgery carries a 97% probability of a higher number of postoperative major complications compared with bariatric surgery alone (OR 1.74), without a mortality difference, and whether prophylactic cholecystectomy fits even the lithiasic gallbladder remains arguable.^[19] The evidence-based prophylaxis is pharmacological: ursodeoxycholic acid across 11 randomised trials (2,363 patients) cut gallstone formation (OR 0.25), symptomatic disease (OR 0.29) and cholecystectomy (OR 0.33).^[20] Outside bariatric prophylaxis, dissolution therapy has no routine role in the surgical management of established symptomatic stones — surgery or observation carries the evidence.

Operative management and the duct-clearance evidence

Symptomatic gallbladder stones are treated with laparoscopic cholecystectomy; the operative craft — critical view of safety, bail-out, timing in acute cholecystitis — belongs to the acute cholecystitis topic, whose WSES 2020 anchor is that early laparoscopic cholecystectomy should be the standard of care whenever possible, even in fragile subgroups.^[21]

After ERCP for choledocholithiasis, ESGE recommends performing laparoscopic cholecystectomy within 2 weeks of ERCP to reduce the conversion rate and the risk of recurrent biliary events.^[1]

One stage or two? The Cochrane review of 16 randomised trials and 1,758 participants frames the modern answer.^[3]

• Historical era: open bile duct surgery achieved significantly fewer retained stones than ERCP (6% versus 16%) — open clearance was superior to endoscopy in the early endoscopy era.^[3]
• Laparoscopic era: single-stage laparoscopic cholecystectomy with bile duct exploration versus pre-operative ERCP plus cholecystectomy showed no significant difference in mortality (0.7% versus 1%) or morbidity (15% versus 13%), and no significant difference in retained stones or failure rates between single-stage laparoscopic clearance and two-stage endoscopic management overall.^[3]
• EAES ductal stone study: equivalent success rates and patient morbidity between the two options, but a shorter hospital stay — a cost benefit — with single-stage laparoscopic treatment; and within the single-stage arm, transcystic duct extraction was a more benign procedure than transcholedochal (supraduodenal) exploration, with a significantly shorter stay.^[4]

Frame the choice for the examiner with the ASGE number: ERCP is minimally invasive but carries adverse events in 6–15%, so a two-stage pathway is not a free option either — the decision is between two equivalent-clearance strategies whose morbidity profiles and local expertise differ.^[2]

The fistulising syndromes

Mirizzi syndrome

Chronic complications of symptomatic gallstone disease such as Mirizzi syndrome are rare in Western developed countries — incidence under 1% a year — though Beltrán's Chilean series found Mirizzi in 5.7% of 5,673 cholecystectomies, a reminder that prevalence is population-dependent.^[14][15] The mechanism is the pressure-ulcer sequence above; the classification logic runs from external compression without fistula to cholecystobiliary fistula to the cholecystoenteric associations validated in the modified Csendes/Beltrán classification.^[14][15]

Gallstone ileus

Gallstone ileus is mechanical obstruction by an impacted ectopic stone, responsible for less than 1% of intestinal obstructions, and concentrated in the elderly with concomitant medical illness — the subgroup whose comorbidity drives the outcome.^[16]

Surgical relief of the gastrointestinal obstruction remains the mainstay of operative treatment, and the three procedures to recite are: (1) simple enterolithotomy — relieve the obstruction and stop; (2) the one-stage procedure — enterolithotomy plus cholecystectomy and fistula closure; (3) the two-stage procedure — enterolithotomy with cholecystectomy performed later. Bowel resection is necessary in certain cases.^[16] The fellowship answer matches the operation to the physiology: in the unfit elderly patient with comorbidity — the typical host — enterolithotomy alone deals with the emergency without adding a difficult cholecystectomy beside a fistula to an already high-risk operation.^[16]

Porcelain gallbladder

Porcelain gallbladder — gallbladder wall calcification on imaging — is rare and matters because of its association with gallbladder cancer, quoted at 5–22% in contemporary reviews.^[18] The historical teaching was far more alarming — incidence quoted between 12% and 61% — and the MGH series is what corrected it.^[17] Stephen and Berger showed the risk depends on the pattern of calcification: selective mucosal wall calcification carried a cancer incidence of approximately 7% with a significant association (odds ratio 13.89), while there were no cancers among gallbladders with diffuse intramural calcification. Their conclusion is the exam answer: a calcified gallbladder is associated with an increased risk of gallbladder cancer, but at a much lower rate than previously estimated; selective mucosal calcification poses the significant risk, diffuse intramural calcification does not.^[17]

Complications and pitfalls

Untreated gallstones complicate in Friedman's frequency order: acute cholecystitis is the most common severe complication; obstructive jaundice, cholangitis, pancreatitis and gallbladder cancer are infrequent.^[7] The treatment harms to weigh against them: routine prophylactic cholecystectomy applies an operative mortality to a 1–2%-per-year event rate, which is precisely why the Ransohoff analysis comes out negative;^[8] ERCP carries adverse events in 6–15%;^[2] and operating on dyspepsia misattributed to stones manufactures persistent post-cholecystectomy symptoms.^[11]

Special populations

The elderly patient with gallstone ileus. The disease concentrates in the elderly with concomitant illness; comorbidity, not the stone, drives mortality. Enterolithotomy alone is the defensible operation in the unfit; the one-stage procedure belongs to the physiologically robust.^[16]

The bariatric patient. De novo gallstone disease in 20.7%, symptomatic disease in 8.2% — prevent with ursodeoxycholic acid (OR 0.25 for formation), and do not add a prophylactic cholecystectomy that brings a 97% probability of more major complications without mortality benefit.^[19][20]

The 35-year-old with incidental stones. Counsel with the cohort numbers: fewer than 20% develop events over 17 years, progression is 0.10/0.19/0.26 at 5/10/15 years in meta-analysis, and prophylactic surgery loses — not gains — days of life expectancy. Document the risk markers (large, multiple, older stones; female sex) and the symptoms that would change the advice.^[8][10][12]

Pregnancy. Gallstone disease in pregnancy is managed conservatively where possible; the operative and severity detail belongs to the acute cholecystitis topic, which is deliberately conservative here — this overview adds only that the natural-history and risk-factor logic is unchanged.^[21]

Evidence landscape and where it is thin

The guideline set for this topic is ESGE 2019 for endoscopic duct-stone management and ASGE 2019 for the role of endoscopy in choledocholithiasis, with WSES 2020 (cholecystitis) and the Tokyo Guidelines (severity grading) living in the cross-referenced topics.^[1][2][21] The duct-clearance comparison rests on the Cochrane 2013 review — 16 trials, 1,758 participants — and the EAES multicentre trial.^[3][4] The watchful-waiting edifice stands on four cohorts and analyses: GREPCO, Friedman's review, the Copenhagen MONICA cohorts, and the 2026 meta-analysis.^{[5][7][10][12]} The evidence is genuinely thin in two places an examiner may probe: incidental IOC stones, where every study is non-randomised and the observed-versus-ERCP numbers (20.9% symptomatic; 50.6% persistent) come from heterogeneous cohorts;^[22] and Mirizzi syndrome management, where no randomised trials exist and classification-based surgical series carry the weight.^[14][15]

Revision summary

• The spectrum: asymptomatic stones → biliary colic (transient impaction) → cholecystitis (sustained impaction) → ductal complications → fistulising syndromes; 10–18% of cholecystectomy patients harbour duct stones.^[3][5]
• Watchful waiting is evidence-based: GREPCO colic 25.8% by 10 years with 3.0% complications; Friedman 1–2%/yr; Copenhagen 19.6% events over 17.4 years; meta-analysis progression 0.10/0.19/0.26 at 5/10/15 years; Ransohoff prophylaxis loses 4–18 days of life.^{[5][7][8][10][12]}
• Risk markers: stones over 10 mm (HR 2.31, cholecystitis HR 9.49), multiple stones (CBD stones HR 11.83), older stones, female sex; dyspepsia and IBS-type symptoms predict nothing.^[10][11]
• Choledocholithiasis: LFTs plus ultrasound first; EUS/MRCP for persistent suspicion; extraction for all fit patients; LC within 2 weeks of ERCP; single-stage equals two-stage for mortality and morbidity (Cochrane), shorter stay single-stage (EAES), transcystic gentler than transcholedochal.^[1][3][4]
• Bariatric: UDCA (formation OR 0.25, symptomatic OR 0.29, cholecystectomy OR 0.33), not prophylactic cholecystectomy (97% probability of more major complications).^[19][20]
• Mirizzi: pressure ulcer to fistula, under 1%/yr in the West, bile-duct-injury danger; 89.5% of cholecystoenteric fistulas had associated Mirizzi.^[14][15]
• Gallstone ileus: under 1% of obstructions, elderly with comorbidity, enterolithotomy first, one- or two-stage by physiology.^[16]
• Porcelain gallbladder: cancer association 5–22%; selective mucosal calcification ~7% (OR 13.89), complete intramural calcification none — pattern, not label.^[17][18]

Cochrane mortality/morbidity equivalent, retained stones 8% versus 14% (NS overall; significantly fewer with LCBDE than postoperative ERCP, 9% vs 25%).^[3]